Proteomic Analysis of and Immune Responses to Ehrlichia Chaffeensis Lipoproteins

Haibin Huang,Mingqun Lin,Xueqi Wang,Takane Kikuchi,Heather Mottaz,Angela Norbeck,Yasuko Rikihisa
DOI: https://doi.org/10.1128/iai.00056-08
2008-01-01
Infection and Immunity
Abstract:ABSTRACTEhrlichia chaffeensisis an obligately intracellular gram-negative bacterium and is the etiologic agent of human monocytic ehrlichiosis (HME). AlthoughE. chaffeensisinduces the generation of several cytokines and chemokines by leukocytes,E. chaffeensislacks lipopolysaccharide and peptidoglycan. Bioinfomatic analysis of theE. chaffeensisgenome, however, predicted genes encoding 15 lipoproteins and 3 posttranslational lipoprotein-processing enzymes. The present study showed that by use of multidimensional liquid chromatography followed by tandem mass spectrometry, all predicted lipoproteins as well as lipoprotein-processing enzymes were expressed byE. chaffeensiscultured in the human promyelocytic leukemia cell line HL-60. Consistent with this observation, a signal peptidase II inhibitor, globomycin, was found to inhibitE. chaffeensisinfection and lipoprotein processing in HL-60 cell culture. To study in vivoE. chaffeensislipoprotein expression and host immune responses toE. chaffeensislipoproteins, 13E. chaffeensislipoprotein genes were cloned into a mammalian expression vector. When the DNA constructs were inoculated into naïve dogs, or when dogs were infected withE. chaffeensis, the animals developed delayed-type hypersensitivity reactions at cutaneous sites of the DNA construct deposition and serum antibodies to these lipoproteins. This is the first demonstration of lipoprotein expression and elicitation of immune responses by a member of the orderRickettsiales. Multiple lipoproteins expressed byE. chaffeensisin vitro and in vivo may play key roles in pathogenesis and immune responses in HME.
What problem does this paper attempt to address?